{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:01:57Z","timestamp":1791237717041,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.medmal.2011.07.005","type":"journal-article","created":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T23:41:25Z","timestamp":1327707685000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy"],"prefix":"10.1016","volume":"42","author":[{"given":"Yann","family":"Neuzillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt G.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Schito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gualco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1A","key":"10.1016\/j.medmal.2011.07.005_bib0005","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2011.07.005_bib0010","series-title":"Detection, prevention and management of UTIs","author":"Kunin","year":"1997"},{"key":"10.1016\/j.medmal.2011.07.005_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001432-200502000-00009","article-title":"Urinary tract infections in diabetes","volume":"18","author":"Nicolle","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2011.07.005_bib0020","first-page":"10","article-title":"Urinary tract infection in pregnancy","volume":"80","author":"MacLean","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.medmal.2011.07.005_bib0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/313596","article-title":"Recurrent urinary tract infections in postmenopausal women","volume":"30","author":"Raz","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.07.005_bib0030","unstructured":"Grabe M, Bjerklund-Johansen TE, Botto H, Cek M, Naber KG, Tenke P, et al. Guidelines on urological infections. In: European Association of Urology, editor. Guidelines edition 2010. ISBN\/EAN: 978-90-79754r-r70-0."},{"key":"10.1016\/j.medmal.2011.07.005_bib0035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy","volume":"54","author":"Naber","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.medmal.2011.07.005_bib0040","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"Clinical Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.medmal.2011.07.005_bib0045","series-title":"Performance standards for antimicrobial susceptibility testing, 17th Informational supplement","author":"Clinical Laboratory Standards Institute","year":"2007"},{"key":"10.1016\/j.medmal.2011.07.005_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ucl.2007.09.004","article-title":"Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis","volume":"35","author":"Nicolle","year":"2008","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.medmal.2011.07.005_bib0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJM198208193070802","article-title":"Diagnosis of coliform infection in acutely dysuric women","volume":"307","author":"Stamm","year":"1982","journal-title":"New Engl J Med"},{"key":"10.1016\/j.medmal.2011.07.005_bib0060","doi-asserted-by":"crossref","unstructured":"Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34:407\u20133.","DOI":"10.1016\/j.ijantimicag.2009.04.012"},{"issue":"Suppl. 20","key":"10.1016\/j.medmal.2011.07.005_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0924-8579(03)00231-0","article-title":"Why fosfomycin trometanol as first line therapy for uncomplicated UTI?","volume":"22","author":"Schito","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2011.07.005_bib0070","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0924-8579(03)00238-3","article-title":"Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection","volume":"22","author":"Hooton","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2011.07.005_bib0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1244","article-title":"Antibiotic use in ambulatory care in Europe (ESAC data 1997\u20132002): trends, regional differences and seasonal fluctuations","volume":"16","author":"Elseviers","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.medmal.2011.07.005_bib0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.medmal.2010.01.006","article-title":"Impact d\u2019un guide r\u00e9gional pour la prise en charge des infections urinaires sur les pratiques d\u2019antibioth\u00e9rapies","volume":"40","author":"Ruyer","year":"2010","journal-title":"Med Mal Infect"},{"issue":"Suppl. S1","key":"10.1016\/j.medmal.2011.07.005_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/46.suppl_1.15","article-title":"The ECO-SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens\u2013interim report","volume":"46","author":"Kahlmeter","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2011.07.005_bib0090","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0924-8579(03)00229-2","article-title":"Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO SENS study","volume":"22","author":"Kahlmeter","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2011.07.005_bib0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/joc.2005.17.3.251","article-title":"Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines","volume":"17","author":"Fadda","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.medmal.2011.07.005_bib0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","article-title":"Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections","volume":"53","author":"Patel","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.medmal.2011.07.005_bib0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/AAC.30.4.545","article-title":"In vitro susceptibilities of four species of coagulase-negative staphylococci","volume":"30","author":"Fass","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2011.07.005_bib0110","first-page":"399","article-title":"Single-dose treatment of cystitis with fosfomycin trometanol (Monuril): analysis of 15 comparative trials on 2048 patients","volume":"19","author":"Lecomte","year":"1997","journal-title":"Giorn It Ost Gin"},{"key":"10.1016\/j.medmal.2011.07.005_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","article-title":"A comparison between single-dose fosfomycin trometanol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women","volume":"10","author":"Minassian","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2011.07.005_bib0120","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2011.07.005_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/46.suppl_1.35","article-title":"Pivmecillinam in the treatment of urinary tract infections","volume":"46","author":"Nicolle","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2011.07.005_bib0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","author":"Nicolle","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2011.07.005_bib0135","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","author":"Gupta","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medmal.2011.07.005_bib0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00006254-199606000-00021","article-title":"Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature","volume":"51","author":"Boggess","year":"1996","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.medmal.2011.07.005_bib0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial","volume":"293","author":"Hooton","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2011.07.005_bib0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01739308","article-title":"Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women","volume":"21","author":"Naber","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2011.07.005_bib0155","unstructured":"Medical Microbiology \u2013 Susceptibility testing of microbial pathogens against chemotherapeutics \u2013 part 4: Breakpoints for minimal inhibitory concentrations \u2013 MIC breakpoints of antibacterial substances Supplement to DIN 58940, edition 1st August 2005. Beuth, Berlin, DIN 58940-4 Bbl 1:2004."},{"issue":"Suppl. S1","key":"10.1016\/j.medmal.2011.07.005_bib0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/46.suppl_1.49","article-title":"Survey on antibiotic usage in the treatment of urinary tract infections","volume":"46","author":"Naber","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2011.07.005_bib0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.07.005_bib0170","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","article-title":"Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with high prevalence of TMP-SMX resistant uropathogens","volume":"34","author":"Raz","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X1100223X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X1100223X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:10:41Z","timestamp":1759972241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X1100223X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0399077X1100223X"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2011.07.005","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2011.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}